Annual Total Debt:
$63.65B-$7.20B(-10.16%)Summary
- As of today (April 12, 2025), PFE annual total debt is $63.65 billion, with the most recent change of -$7.20 billion (-10.16%) on December 1, 2024.
- During the last 3 years, PFE annual total debt has risen by +$26.65 billion (+72.03%).
- PFE annual total debt is now -10.16% below its all-time high of $70.84 billion, reached on December 31, 2023.
Performance
PFE Total debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Total Debt:
$63.65B-$2.97B(-4.46%)Summary
- As of today (April 12, 2025), PFE quarterly total debt is $63.65 billion, with the most recent change of -$2.97 billion (-4.46%) on December 1, 2024.
- Over the past year, PFE quarterly total debt has stayed the same.
- PFE quarterly total debt is now -10.16% below its all-time high of $70.84 billion, reached on December 31, 2023.
Performance
PFE Quarterly Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Total debt Formula
Total Debt = Short Term Debt + Long Term Debt
PFE Total debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -10.2% | 0.0% |
| 3 y3 years | +72.0% | 0.0% |
| 5 y5 years | +25.2% | 0.0% |
PFE Total debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -10.2% | +82.6% | -10.2% | +82.6% |
| 5 y | 5-year | -10.2% | +82.6% | -10.2% | +82.6% |
| alltime | all time | -10.2% | >+9999.0% | -10.2% | >+9999.0% |
Pfizer Total debt History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $63.65B(-10.2%) | $63.65B(-4.5%) |
| Sep 2024 | - | $66.62B(-3.0%) |
| Jun 2024 | - | $68.68B(-0.0%) |
| Mar 2024 | - | $68.71B(-3.0%) |
| Dec 2023 | $70.84B(+103.2%) | $70.84B(+11.4%) |
| Sep 2023 | - | $63.60B(-2.7%) |
| Jun 2023 | - | $65.34B(+87.1%) |
| Mar 2023 | - | $34.93B(+0.2%) |
| Dec 2022 | $34.86B(-5.8%) | $34.86B(-2.3%) |
| Sep 2022 | - | $35.68B(-8.8%) |
| Jun 2022 | - | $39.13B(+11.6%) |
| Mar 2022 | - | $35.05B(-5.3%) |
| Dec 2021 | $37.00B(-3.3%) | $37.00B(-3.7%) |
| Sep 2021 | - | $38.41B(+1.8%) |
| Jun 2021 | - | $37.73B(-1.2%) |
| Mar 2021 | - | $38.19B(-0.2%) |
| Dec 2020 | $38.27B(-24.7%) | $38.27B(-37.8%) |
| Sep 2020 | - | $61.53B(-3.3%) |
| Jun 2020 | - | $63.61B(+21.7%) |
| Mar 2020 | - | $52.28B(+2.8%) |
| Dec 2019 | $50.84B(+21.8%) | $50.84B(-3.4%) |
| Sep 2019 | - | $52.65B(+12.8%) |
| Jun 2019 | - | $46.67B(+3.4%) |
| Mar 2019 | - | $45.14B(+8.1%) |
| Dec 2018 | $41.74B(-2.0%) | $41.74B(-13.8%) |
| Sep 2018 | - | $48.43B(+19.5%) |
| Jun 2018 | - | $40.52B(-0.8%) |
| Mar 2018 | - | $40.83B(-4.2%) |
| Dec 2017 | $42.61B(+3.8%) | $42.61B(-3.1%) |
| Sep 2017 | - | $43.95B(+0.6%) |
| Jun 2017 | - | $43.70B(-0.7%) |
| Mar 2017 | - | $44.01B(+7.2%) |
| Dec 2016 | $41.06B(+5.6%) | $41.06B(-6.8%) |
| Sep 2016 | - | $44.07B(-0.3%) |
| Jun 2016 | - | $44.18B(+12.2%) |
| Mar 2016 | - | $39.37B(+1.2%) |
| Dec 2015 | $38.90B(+6.0%) | $38.90B(+0.0%) |
| Sep 2015 | - | $38.90B(+10.7%) |
| Jun 2015 | - | $35.12B(-2.2%) |
| Mar 2015 | - | $35.92B(-2.1%) |
| Dec 2014 | $36.68B(+0.5%) | $36.68B(-1.0%) |
| Sep 2014 | - | $37.05B(-2.0%) |
| Jun 2014 | - | $37.83B(+2.3%) |
| Mar 2014 | - | $36.97B(+1.3%) |
| Dec 2013 | $36.49B(-2.6%) | $36.49B(-0.2%) |
| Sep 2013 | - | $36.55B(-0.5%) |
| Jun 2013 | - | $36.75B(-9.0%) |
| Mar 2013 | - | $40.38B(+7.8%) |
| Dec 2012 | $37.46B(-3.8%) | $37.46B(-3.6%) |
| Sep 2012 | - | $38.86B(+0.7%) |
| Jun 2012 | - | $38.57B(-1.3%) |
| Mar 2012 | - | $39.07B(+0.3%) |
| Dec 2011 | $38.94B(-11.6%) | $38.94B(-5.1%) |
| Sep 2011 | - | $41.04B(-1.6%) |
| Jun 2011 | - | $41.71B(+0.7%) |
| Mar 2011 | - | $41.40B(-6.0%) |
| Dec 2010 | $44.03B(-9.5%) | $44.03B(-0.3%) |
| Sep 2010 | - | $44.17B(+2.1%) |
| Jun 2010 | - | $43.27B(-6.0%) |
| Mar 2010 | - | $46.05B(-5.4%) |
| Dec 2009 | $48.66B(+181.6%) | $48.66B(+5.3%) |
| Sep 2009 | - | $46.20B(-0.7%) |
| Jun 2009 | - | $46.54B(+31.3%) |
| Mar 2009 | - | $35.45B(+105.1%) |
| Dec 2008 | $17.28B(+31.5%) | $17.28B(+5.7%) |
| Sep 2008 | - | $16.34B(-2.1%) |
| Jun 2008 | - | $16.69B(-2.1%) |
| Mar 2008 | - | $17.05B(+29.8%) |
| Dec 2007 | $13.14B(+64.6%) | $13.14B(+51.3%) |
| Sep 2007 | - | $8.69B(+5.8%) |
| Jun 2007 | - | $8.21B(+10.8%) |
| Mar 2007 | - | $7.41B(-7.2%) |
| Dec 2006 | $7.98B(-55.5%) | $7.98B(-1.1%) |
| Sep 2006 | - | $8.07B(-12.6%) |
| Jun 2006 | - | $9.23B(-20.2%) |
| Mar 2006 | - | $11.57B(-35.5%) |
| Dec 2005 | $17.94B(-3.3%) | $17.94B(+47.7%) |
| Sep 2005 | - | $12.14B(-5.0%) |
| Jun 2005 | - | $12.78B(-35.6%) |
| Mar 2005 | - | $19.83B(+6.9%) |
| Dec 2004 | $18.55B | $18.55B(-1.4%) |
| Sep 2004 | - | $18.81B(-0.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2004 | - | $18.97B(+6.4%) |
| Mar 2004 | - | $17.84B(+22.4%) |
| Dec 2003 | $14.57B(+23.4%) | $14.57B(-8.0%) |
| Sep 2003 | - | $15.84B(+6.1%) |
| Jun 2003 | - | $14.92B(+15.0%) |
| Mar 2003 | - | $12.98B(+9.9%) |
| Dec 2002 | $11.81B(+33.1%) | $11.81B(-14.5%) |
| Sep 2002 | - | $13.81B(+20.7%) |
| Jun 2002 | - | $11.44B(+10.8%) |
| Mar 2002 | - | $10.33B(+16.4%) |
| Dec 2001 | $8.87B(+63.9%) | $8.87B(+5.0%) |
| Sep 2001 | - | $8.45B(+20.6%) |
| Jun 2001 | - | $7.00B(+19.7%) |
| Mar 2001 | - | $5.85B(+8.1%) |
| Dec 2000 | $5.41B(-23.5%) | $5.41B(-24.7%) |
| Sep 2000 | - | $7.19B(+5.6%) |
| Jun 2000 | - | $6.81B(+60.6%) |
| Mar 2000 | - | $4.24B(-40.0%) |
| Dec 1999 | $7.07B(+117.2%) | $7.07B(+17.7%) |
| Sep 1999 | - | $6.01B(+9.9%) |
| Jun 1999 | - | $5.47B(+13.4%) |
| Mar 1999 | - | $4.82B(+48.1%) |
| Dec 1998 | $3.26B(+9.4%) | $3.26B(-16.0%) |
| Sep 1998 | - | $3.88B(+17.3%) |
| Jun 1998 | - | $3.31B(+1.9%) |
| Mar 1998 | - | $3.24B(+9.0%) |
| Dec 1997 | $2.98B(+1.8%) | $2.98B(-16.9%) |
| Sep 1997 | - | $3.58B(-3.5%) |
| Jun 1997 | - | $3.71B(+11.9%) |
| Mar 1997 | - | $3.31B(+13.4%) |
| Dec 1996 | $2.92B(+1.9%) | $2.92B(-21.2%) |
| Sep 1996 | - | $3.71B(+18.6%) |
| Jun 1996 | - | $3.13B(+7.0%) |
| Mar 1996 | - | $2.92B(+1.9%) |
| Dec 1995 | $2.87B(+1.6%) | $2.87B(-15.7%) |
| Sep 1995 | - | $3.40B(-7.2%) |
| Jun 1995 | - | $3.67B(-1.5%) |
| Mar 1995 | - | $3.73B(+31.9%) |
| Dec 1994 | $2.82B(+61.4%) | $2.82B(+18.5%) |
| Sep 1994 | - | $2.38B(-1.0%) |
| Jun 1994 | - | $2.41B(+15.3%) |
| Mar 1994 | - | $2.09B(+19.4%) |
| Dec 1993 | $1.75B(-4.1%) | $1.75B(-37.4%) |
| Sep 1993 | - | $2.79B(+2.1%) |
| Jun 1993 | - | $2.73B(+13.3%) |
| Mar 1993 | - | $2.41B(+32.4%) |
| Dec 1992 | $1.82B(-12.7%) | $1.82B(-2.2%) |
| Sep 1992 | - | $1.86B(+13.9%) |
| Jun 1992 | - | $1.64B(-12.6%) |
| Mar 1992 | - | $1.87B(-10.3%) |
| Dec 1991 | $2.09B(+23.3%) | $2.09B(+14.9%) |
| Sep 1991 | - | $1.82B(+5.9%) |
| Jun 1991 | - | $1.72B(+19.3%) |
| Mar 1991 | - | $1.44B(-15.0%) |
| Dec 1990 | $1.69B(-1.4%) | $1.69B(+16.9%) |
| Sep 1990 | - | $1.45B(+14.0%) |
| Jun 1990 | - | $1.27B(+7.7%) |
| Mar 1990 | - | $1.18B(-31.3%) |
| Dec 1989 | $1.72B(+43.7%) | $1.72B(>+9900.0%) |
| Sep 1989 | - | $0.00(0.0%) |
| Jun 1989 | - | $0.00(0.0%) |
| Mar 1989 | - | $0.00(-100.0%) |
| Dec 1988 | $1.19B(+23.9%) | $1.19B(>+9900.0%) |
| Sep 1988 | - | $0.00(0.0%) |
| Jun 1988 | - | $0.00(0.0%) |
| Mar 1988 | - | $0.00(-100.0%) |
| Dec 1987 | $963.80M(+73.1%) | $963.80M(>+9900.0%) |
| Sep 1987 | - | $0.00(0.0%) |
| Jun 1987 | - | $0.00(0.0%) |
| Mar 1987 | - | $0.00(-100.0%) |
| Dec 1986 | $556.70M(+9.3%) | $556.70M(>+9900.0%) |
| Sep 1986 | - | $0.00(0.0%) |
| Jun 1986 | - | $0.00(0.0%) |
| Mar 1986 | - | $0.00(-100.0%) |
| Dec 1985 | $509.40M(-20.1%) | $509.40M(>+9900.0%) |
| Sep 1985 | - | $0.00(0.0%) |
| Jun 1985 | - | $0.00(0.0%) |
| Mar 1985 | - | $0.00(-100.0%) |
| Dec 1984 | $637.20M | $637.20M(>+9900.0%) |
| Sep 1984 | - | $0.00(0.0%) |
| Jun 1984 | - | $0.00(0.0%) |
| Mar 1984 | - | $0.00 |
FAQ
- What is Pfizer annual total debt?
- What is the all time high annual total debt for Pfizer?
- What is Pfizer annual total debt year-on-year change?
- What is Pfizer quarterly total debt?
- What is the all time high quarterly total debt for Pfizer?
- What is Pfizer quarterly total debt year-on-year change?
What is Pfizer annual total debt?
The current annual total debt of PFE is $63.65B
What is the all time high annual total debt for Pfizer?
Pfizer all-time high annual total debt is $70.84B
What is Pfizer annual total debt year-on-year change?
Over the past year, PFE annual total debt has changed by -$7.20B (-10.16%)
What is Pfizer quarterly total debt?
The current quarterly total debt of PFE is $63.65B
What is the all time high quarterly total debt for Pfizer?
Pfizer all-time high quarterly total debt is $70.84B
What is Pfizer quarterly total debt year-on-year change?
Over the past year, PFE quarterly total debt has changed by $0.00 (0.00%)